GuruFundPicks
Contributor since: 2011
Company: GuruFundPicks.com
Latest Articles
Don't Be Afraid Of Jumping Into The Big Rally In Quantum
Be Careful Before You Jump Into Yet Another Rally In Sysorex
Winners Circle Q1 2015 Top Hedge Fund Managers: Healthcare Funds Again Top The List
Ideal Power May Be Ideal To Power Your Portfolio
Winners Circle 2014 Top Hedge Fund Managers: Healthcare Funds, Nine Of Top Ten Spots
Guru Fund Managers Would Buy LinkedIn Shares Here. Should You?
Endocyte Is A Steal At Current Prices, Appropriate For The Risk-Tolerant Investor
Plug Power's Secondary A Net Positive, But There Are Other Issues To Lose Sleep Over
Can Endo's CEO Do An Encore Of His Playbook At Valeant? Guru Funds Think So.
Is There Any Power Left In Plug Power? Guru Funds Don't Think So.
Could Guru Fund Managers Be Right On Apple Again?
Is Imperva The Worst Name In Cyber-Security Or Has It Fallen A Bit Too Much?
Buy Actavis - An Attractive Value And Growth Play That Is Also A Top Guru Fund Pick
Join Gurus And Buy Value And Growth Play Micron At Cheap Prices
Will The Third Time Be A Charm For MannKind? Leading Fund Managers Definitely Think So
Guru Fund Managers Are Heavily Accumulating BlackBerry Shares. Should You?
Take Advantage Of Legislative Grandstanding By Buying Gilead At A Discount
Leading Fund Managers Are Still Heavily Accumulating Facebook Shares... Should You?
Gilead Is Not Done; There Is Potentially 50% More Upside This Year
Rexahn Pharmaceutical Shares Are Still A Buy Despite Recent Volatility
FireEye's Game-Changing Acquisition Of Mandiant Makes It An Ideal Long-Term Buy
Plug Power Shares Have Great Long-Term Potential, But Are Vulnerable In The Short Term
Twitter's Bubble Has Burst. Get Ready To Short The Double-Top
DryShips Shares Are A Better Value Than Its Drybulk Peers
Don't Buy Ariad Pharmaceuticals Shares At These Levels
Immunocellular Shares Are Set For A Rebound
Patient, Provider, Insurer, And Government Interests Aligned For 100% Upside On Rockwell Medical
Organovo: Love The Technology, Like The Company, But Wait To Buy The Stock
Strengthen Your Portfolio With U.S. Silica: Potential Double In 12-18 Months
Predicting Biotech Stock Moves Based On Consensus Picks By Legendary Fund Managers
A Perfect Trifecta For Thompson Creek
Oxford Resource Partners Offers Multi-Bagger Potential Despite Its Problems